BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32346211)

  • 1. Antiemetic drugs: what to prescribe and when.
    Athavale A; Athavale T; Roberts DM
    Aust Prescr; 2020 Apr; 43(2):49-56. PubMed ID: 32346211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic optimisation of antiemetic therapy.
    Campbell M; Bateman DN
    Clin Pharmacokinet; 1992 Aug; 23(2):147-60. PubMed ID: 1355018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of postoperative nausea and vomiting.
    Kovac AL
    Drugs; 2000 Feb; 59(2):213-43. PubMed ID: 10730546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics.
    May MB; Glode AE
    Cancer Manag Res; 2016; 8():49-55. PubMed ID: 27274310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron: a review of its use as an antiemetic in children.
    Culy CR; Bhana N; Plosker GL
    Paediatr Drugs; 2001; 3(6):441-79. PubMed ID: 11437189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced nausea and vomiting.
    Lohr L
    Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron. Therapeutic use as an antiemetic.
    Milne RJ; Heel RC
    Drugs; 1991 Apr; 41(4):574-95. PubMed ID: 1711961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of dexamethasone in the decrease of chemotherapy-induced nausea and vomiting.
    Sarcev T; Secen N; Povazan Dj; Sabo A; Popovic J; Bursac D; Kakas M; Zaric B; Milovancev A
    J BUON; 2007; 12(2):245-52. PubMed ID: 17600880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
    Grunberg SM
    Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.
    Perwitasari DA; Wessels JA; van der Straaten RJ; Baak-Pablo RF; Mustofa M; Hakimi M; Nortier JW; Gelderblom H; Guchelaar HJ
    Jpn J Clin Oncol; 2011 Oct; 41(10):1168-76. PubMed ID: 21840870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antiemetic therapy with ondansetron, tropisetron, granisetron and metoclopramide in patients undergoing laparoscopic cholecystectomy: a randomized, double-blind comparison with placebo.
    Naguib M; el Bakry AK; Khoshim MH; Channa AB; el Gammal M; el Gammal K; Elhattab YS; Attia M; Jaroudi R; Saddique A
    Can J Anaesth; 1996 Mar; 43(3):226-31. PubMed ID: 8829860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic care for patients with breast cancer: focus on drug interactions and safety concerns.
    Georgy A; Neceskas J; Goodin S
    Am J Health Syst Pharm; 2007 Nov; 64(21):2227-36. PubMed ID: 17959573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing antiemetic therapy in multiple-day and multiple cycles of chemotherapy.
    Ellebaek E; Herrstedt J
    Curr Opin Support Palliat Care; 2008 Mar; 2(1):28-34. PubMed ID: 18685391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy?
    Schwartzberg LS
    Oncology (Williston Park); 2007 Jul; 21(8):946-53; discussion 954, 959, 962 passim. PubMed ID: 17715696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.
    Plosker GL; Benfield P
    Pharmacoeconomics; 1996 Apr; 9(4):357-74. PubMed ID: 10160110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.